Michael McCaul sold NBIX on May 2, 2023 | PolitAlpha
Michael McCaul sold NBIX (Neurocrine Biosciences Inc) on May 2, 2023 with an estimated value between $15,000 and $50,000. This trade was filed under spouse. The stock is currently up 27.2% from the trade price.